Complete Filing Data
Creative Global Technology Holdings Ltd reported Stockholders Equity of $18.04 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Creative Global Technology Holdings Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Selling And Marketing Expense | $25.5K | $32.7K | $34.1K | $39.6K |
| Revenues | $21.2M | $35.6M | $50.3M | $27.9M |
| Other Nonoperating Income | $1.2K | $5.3K | $30.5K | $34.3K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$14.2K | -$21.7K | $24.7K | -$21.9K |
| Operating Income Loss | -$13.2M | $5.2M | $3.8M | $4.0M |
| Operating Expenses | $15.4M | $1.2M | $1.2M | $407.8K |
| Nonoperating Income Expense | $2.7K | $118.00 | $40.8K | $7.6K |
| Net Income Loss | -$13.4M | $4.3M | $3.2M | $3.4M |
| Interest Income Expense Nonoperating Net | $1.5K | -$2.4K | $10.3K | $16.00 |
| Income Tax Expense Benefit | $212.1K | $903.3K | $679.8K | $642.5K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.2M | $5.2M | $3.8M | $4.0M |
| Gross Profit | $2.3M | $6.3M | $5.0M | $4.4M |
| General And Administrative Expense | $1.2M | $1.1M | $1.1M | $368.2K |
| Cost Of Revenue | $18.9M | $29.3M | $45.3M | $23.4M |
| Comprehensive Income Net Of Tax | -$13.4M | $4.3M | $3.2M | $3.4M |
| Other Nonoperating Expense | $2.7K | $26.7K | ||
| Deferred Income Tax Liabilities Net | $266.00 | $2.4K | ||
| Provision For Inventory Impairment | $104.6K | |||
| Deferred Income Tax Assets Net | $19.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $18.0M | $13.5M | $9.2M | $6.0M | $2.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $185.2K | $443.3K | $4.3M | $959.3K | $297.9K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$258.1K | -$3.9M | $3.3M | $661.4K | |
| Taxes Payable Current | $88.2K | $2.7M | $1.8M | ||
| Retained Earnings Accumulated Deficit | $86.1K | $13.5M | $9.2M | ||
| Property Plant And Equipment Net | $9.8K | $26.6K | $15.9K | ||
| Prepaid Expense And Other Assets Current | $3.4M | $538.2K | $762.5K | ||
| Liabilities Current | $251.5K | $2.8M | $2.2M | ||
| Liabilities And Stockholders Equity | $18.3M | $16.3M | $11.4M | ||
| Liabilities | $251.5K | $2.9M | $2.2M | ||
| Inventory Net | $14.7M | $3.8M | $5.8M | ||
| Cash And Cash Equivalents At Carrying Value | $185.2K | $443.3K | $4.3M | ||
| Assets Noncurrent | $48.1K | $1.0M | $570.1K | ||
| Assets Current | $18.2M | $15.3M | $10.8M | ||
| Assets | $18.3M | $16.3M | $11.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$29.8K | -$15.6K | $6.1K | ||
| Accounts Payable And Other Accrued Liabilities Current | $144.4K | $56.2K | $428.7K | ||
| Operating Lease Right Of Use Asset | $18.5K | $123.4K | |||
| Operating Lease Liability Current | $18.7K | $108.2K | |||
| Liabilities Noncurrent | $18.9K | $2.4K | |||
| Deferred Offering Costs | $854.7K | $554.2K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $74.1K | ||||
| Operating Lease Liability Noncurrent | $18.7K | ||||
| Common Stock Value | $20.0K | $20.0K | |||
| Accounts Receivable Net Current | $10.5M | ||||
| Additional Paid In Capital Common Stock | $18.0M | ||||
| Accounts Payable Current | $209.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.8M | -$3.5M | $4.9M | $654.5K |
| Net Cash Provided By Used In Financing Activities | $4.6M | -$299.3K | -$1.5M | $44.5K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.8M | -$227.3K | -$2.5M | $1.0M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $88.0K | -$374.7K | $419.0K | -$1.6M |
| Increase Decrease In Inventories | $10.9M | -$1.9M | $1.9M | $808.0K |
| Increase Decrease In Deferred Income Taxes | $19.7K | $2.2K | $603.00 | -$2.1K |
| Increase Decrease In Accrued Income Taxes Payable | -$2.6M | $914.8K | $673.2K | $634.5K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$31.1K | -$20.2K | $21.7K | -$20.4K |
| Payments To Acquire Property Plant And Equipment | $18.6K | $3.8K | $17.1K | |
| Payments Of Stock Issuance Costs | $272.3K | $299.3K | $554.0K | |
| Net Cash Provided By Used In Investing Activities | -$18.6K | -$3.8K | -$17.1K | |
| Proceeds From Payments For Other Financing Activities | -$992.2K | $44.5K | ||
| Increase Decrease In Right Of Use Assets | $104.8K | -$197.6K | ||
| Increase Decrease In Other Noncurrent Liabilities | -$266.00 | $18.7K | ||
| Increase Decrease In Other Current Liabilities | -$108.1K | $108.5K | ||
| Increase Decrease In Accounts Receivable | -$10.5M | $10.5M | ||
| Stock Issued During Period Value Share Based Compensation | $14.2M | |||
| Share Based Compensation | $14.2M | |||
| Proceeds From Issuance Of Common Stock | $4.9M | |||
| Increase Decrease In Accounts Payable | $209.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 23.6M | 20.0M | 20.0M | 20.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 23.6M | 20.0M | 20.0M | 20.0M |
| Earnings Per Share Diluted | $-0.57 | $0.21 | $0.16 | $0.17 |
| Earnings Per Share Basic | $-0.57 | $0.21 | $0.16 | $0.17 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 20.0M | 20.0M | ||
| Common Stock Shares Issued | 20.0M | 20.0M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Depreciation | $16.7K | $7.9K | $6.9K | $4.1K |
| Stock Issued During Period Value Other | $17.2K | |||
| Stock Issued During Period Value Ordinary Shares | 8.5K | |||
| Stock Issued During Period Value New Issues | $3.7M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | -$25.7K |
Most recent annual filing with the SEC: January 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.